rs150107590

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_144991.3(TSPEAR):​c.44C>T​(p.Ala15Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,611,590 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 10 hom. )

Consequence

TSPEAR
NM_144991.3 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.34
Variant links:
Genes affected
TSPEAR (HGNC:1268): (thrombospondin type laminin G domain and EAR repeats) This gene encodes a protein that contains a N-terminal thrombospondin-type laminin G domain and several tandem arranged epilepsy-associated repeats (EARs). A mutation in this gene is the cause of autosomal recessive deafness-98. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006333798).
BP6
Variant 21-44711471-G-A is Benign according to our data. Variant chr21-44711471-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 228053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-44711471-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00192 (292/152364) while in subpopulation AMR AF= 0.00588 (90/15306). AF 95% confidence interval is 0.0049. There are 1 homozygotes in gnomad4. There are 144 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSPEARNM_144991.3 linkc.44C>T p.Ala15Val missense_variant Exon 1 of 12 ENST00000323084.9 NP_659428.2 Q8WU66-1
TSPEARNM_001272037.2 linkc.-223C>T 5_prime_UTR_variant Exon 1 of 13 NP_001258966.1 Q8WU66

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSPEARENST00000323084.9 linkc.44C>T p.Ala15Val missense_variant Exon 1 of 12 1 NM_144991.3 ENSP00000321987.4 Q8WU66-1
TSPEARENST00000642437.1 linkn.44C>T non_coding_transcript_exon_variant Exon 1 of 13 ENSP00000496535.1 A0A2R8YFK6

Frequencies

GnomAD3 genomes
AF:
0.00193
AC:
294
AN:
152246
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00595
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00394
Gnomad FIN
AF:
0.00103
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00245
AC:
596
AN:
243458
Hom.:
2
AF XY:
0.00262
AC XY:
347
AN XY:
132556
show subpopulations
Gnomad AFR exome
AF:
0.000460
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00365
Gnomad EAS exome
AF:
0.000110
Gnomad SAS exome
AF:
0.00398
Gnomad FIN exome
AF:
0.00177
Gnomad NFE exome
AF:
0.00272
Gnomad OTH exome
AF:
0.00271
GnomAD4 exome
AF:
0.00253
AC:
3690
AN:
1459226
Hom.:
10
Cov.:
30
AF XY:
0.00254
AC XY:
1845
AN XY:
725778
show subpopulations
Gnomad4 AFR exome
AF:
0.000478
Gnomad4 AMR exome
AF:
0.00294
Gnomad4 ASJ exome
AF:
0.00372
Gnomad4 EAS exome
AF:
0.0000757
Gnomad4 SAS exome
AF:
0.00373
Gnomad4 FIN exome
AF:
0.00101
Gnomad4 NFE exome
AF:
0.00256
Gnomad4 OTH exome
AF:
0.00302
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152364
Hom.:
1
Cov.:
32
AF XY:
0.00193
AC XY:
144
AN XY:
74512
show subpopulations
Gnomad4 AFR
AF:
0.000433
Gnomad4 AMR
AF:
0.00588
Gnomad4 ASJ
AF:
0.00461
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00373
Gnomad4 FIN
AF:
0.00103
Gnomad4 NFE
AF:
0.00190
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00265
Hom.:
0
Bravo
AF:
0.00230
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00230
AC:
278
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

TSPEAR: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 28, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Apr 13, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Ala15Val in exon 1 of TSPEAR: This variant is not expected to have clinical si gnificance because it has been identified in 0.4% (118/30330) of South Asian chr omosomes including 1 homozygote by the Genome Aggregation Database (gnomAD, http ://gnomad.broadinstitute.org; dbSNP rs150107590). -

TSPEAR-related disorder Benign:1
Sep 27, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Autosomal recessive nonsyndromic hearing loss 98 Benign:1
Feb 11, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
9.6
DANN
Benign
0.63
DEOGEN2
Benign
0.017
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.48
.;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.0063
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.55
N;N
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.090
.;N
REVEL
Benign
0.053
Sift
Benign
0.30
.;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.26
MVP
0.014
MPC
0.050
ClinPred
0.0055
T
GERP RS
1.9
Varity_R
0.025
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150107590; hg19: chr21-46131386; COSMIC: COSV105901072; API